A Briefing Paper Antibodies and their derivatives, including bispecific and multispecific antibodies, fragments, and fusion products, have become central to…
Read More
A Briefing Paper Antibodies and their derivatives, including bispecific and multispecific antibodies, fragments, and fusion products, have become central to…
Read MoreThe EPO’s Enlarged Board of Appeal (EBA) have issued their decision on G 1/23, providing further clarity to attorneys, patentees and…
Read MoreThe Unified Patent Court (UPC) allows granted European patents to be enforced or challenged centrally and for a single ruling…
Read MoreThis article was originally commissioned and published in CITMA’s online blog, May 2025 Thom Browne and Adidas: two global names…
Read MoreAnne Bate, patent paralegal & technical workflow specialist, joins John to mark their 30-year working partnership along with managing partner…
Read MoreBarker Brettell provides cost-conscious, in-house patent specialists with European expertise Barker Brettell, the UK head-quartered intellectual property (IP) firm, is…
Read MoreApplications for registered EU designs can be filed at the EUIPO and offer a convenient, cost-effective way of obtaining design…
Read MoreThe Enlarged Board of Appeal has issued its preliminary opinion ahead of the upcoming oral proceedings on the G1/24 referral…
Read MoreThe Unified Patent Court, a centralised court having jurisdiction over infringement and validity of European patents in countries which have…
Read MoreThe UK Intellectual Property Office (UK IPO) has recently announced the launch of its new ‘One IPO Search’ tool to…
Read MoreA recent EPO Board of Appeal (BoA) decision (T 1553/22) considered the patentability of human-animal chimeras (organisms or tissues that…
Read MoreIn late December 2024 the UK IPO launched a three-month consultation on AI and copyright – closing on 25th February…
Read More